Navigation Links
Angioplasty death risk reduced by doubling drug dose

A new study shows how the risk of death and heart attack can be reduced for heart patients undergoing an angioplasty.// It was found that doubling the usual dose of an anti-clotting drug before the procedure is the answer.

Angioplasty is a procedure in which a balloon-tipped catheter is threaded into an artery. The balloon is inflated to compress plaque in the artery and unblock the vessel. A small synthetic tube - stent is used to hold the vessel open, but arteries often re-close if blood clots form to protect the body against bleeding.

Patients commonly take the drug clopidogrel (Plavix) before angioplasty to prevent clotting. In this new study, patients received either the standard dose of 300 milligrams or received a dose of 600 milligrams before the procedure.

Following angioplasty it was found out that, 12 percent of patients who took the lower dose died, had a heart attack or needed another procedure. In contrast, only 4 percent of patients in the high-dose group had such an event. Doubling the dosage did not increase the risk of bleeding.

In conclusion, it was evident that the high-dose patients had a 48-percent reduction in heart attack risk compared to those given the standard dose. Additionally, a subgroup of patients taking the higher dose as well as the cholesterol-lowering drugs called statins had an 80-percent reduction.
'"/>




Page: 1

Related medicine news :

1. Cholesterol Drug Helps After Angioplasty
2. Angioplasty Should be the Standard
3. The Success Rate Of Angioplasty In Female Patients Low
4. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
5. Angioplasty death risk reduced by doubling drug dose
6. A ray of hope in Angioplasty dilemma
7. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
8. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
9. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
10. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
11. Togadiyas Condition Stable After Undergoing Angioplasty
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... The Women’s ... has awarded Zyclear Migraine Relief with the 2017 Women’s Choice Award. The identification by ... show that 3 out of 4 migraine sufferers are women. In a survey taken ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... announce the addition of Zack Tisch as the firm’s new Consulting Services Executive. ... IT consulting firm’s national accounts, from assisting clients with initial vendor selection and ...
(Date:8/22/2017)... , ... August 22, 2017 , ... Nurses at ... at picturesque Babcock Cove, recently received training and certification in Closed Pulse Irrigation™ ... has a prestigious five-star rating from the Centers for Medicare and Medicaid Services, to ...
(Date:8/22/2017)... , ... August 22, 2017 , ... “Wilderness Voices”: a ... world travel. “Wilderness Voices” is the creation of published author, Martha McKown, an ... McKown was inspired as a very young child when her older sisters studied High ...
(Date:8/22/2017)... ... 2017 , ... “Glimpses Of Light”: is a unique and thought inspiring ... the creation of published author, J.M. Shepherd, a writer, teacher, traveler, and metaphysician, the ... mysteries. , Shepherd shares, “Love is one of the least understood and yet most ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial ... Company reported second quarter net sales of $1.954 billion, ... and an increase of 2.1% on a constant currency ... the LDR Holding Corporation acquisition, second quarter 2017 revenues ... 0.3% on a constant currency basis. ...
(Date:7/26/2017)... Colo. , July 26, 2017 E.I. ... Guttridge and the Bimini SharkLab to custom design the worlds ... images of sharks in their native habitat. In preparation ... Discovery Channel,s Shark Week, Dr. Guttridge approached EIMI ... take pregnancy diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... 26, 2017 Sancilio Pharmaceuticals Company, Inc. (SPCI) ... trial evaluating Altemia TM , an oral therapy for ... Cell Disease (SCD). The SCOT Trial, is a double-blind, ... safety of Altemia TM in pediatric patients aged ... IND 125274. "The ...
Breaking Medicine Technology: